Do we really need continuous vancomycin infusion in neonates?

Samiee-Zafarghandy, Samira; van den Anker, John N.
December 2013
Archives of Disease in Childhood;Dec2013, Vol. 98 Issue 12, p1023
Academic Journal
A letter to the editor is presented in response to the article "Vancomycin continuous infusion in neonates: dosing optimisation and therapeutic drug monitoring," by W. Zhao, E. Lopez, V. Biran published in the June 2013 issue.


Related Articles

  • Usefulness of serum cystatin C to determine the dose of vancomycin in neonate. Jeong Eun Shin; Soon Min Lee; Ho Seon Eun; Min Soo Park; Kook In Park; Ran Namgung // Korean Journal of Pediatrics;Nov2015, Vol. 58 Issue 11, p421 

    Purpose: The vancomycin dosage regimen is regularly modified according to the patient's glomerular filtration rate (GFR). In the present study, we aimed to assess the usefulness of serum cystatin C (Cys-C) concentration, compared with serum creatinine (SCr) concentration, for predicting...

  • Continuous-infusion vancomycin therapy for preterm neonates with suspected or documented Gram-positive infections: a new dosage schedule. Plan, O.; Cambonie, G.; Barbotte, E.; Meyer, P.; Devine, C.; Milesi, C.; Pidoux, O.; Badr, M.; Picaud, J. C. // Archives of Disease in Childhood -- Fetal & Neonatal Edition;Nov2008, Vol. 93 Issue 6, pF418 

    Background: Intermittent infusion of vancomycin is widely used to treat late-onset sepsis in neonates. On the other hand, the continuous infusion of vancomycin could improve bactericidal efficacy since its action is time dependent. Objective: To evaluate a simplified dosage schedule for...

  • Pharmacokinetic comparison of nomogram-based and individualized vancomycin regimens in neonates. Crumby, Trey; Rinehart, Eliza; Carby, Mollie Cannon; Kuhl, David; Talati, Ajay J. // American Journal of Health-System Pharmacy;1/15/2009, Vol. 66 Issue 2, p149 

    Purpose. This study compared steadystate concentrations achieved with a dosing strategy using first-dose kinetics to individualize vancomycin regimens with the steady-state concentrations achieved using standardized nomograms. Methods. Neonatal intensive care unit patients receiving vancomycin...

  • Giving vancomycin as a continuous infusion. Embleton, N. D.; Berrington, J. // Archives of Disease in Childhood -- Fetal & Neonatal Edition;Mar2009, Vol. 94 Issue 3, pF233 

    A letter to the editor is presented in response to the article "Continuous-Infusion Vancomycin Therapy for Preterm Neonates With Suspected or Documented Gram-Positive Infections: A New Dosage Schedule" by O. Plan published in the journal "Archives of Disease in Childhood--Fetal & Neonatal...

  • Combination of vancomycin and rifampicin for the treatment of persistent coagulase-negative staphylococcal bacteremia in preterm neonates. Rodriguez-Guerineau, Luciana; Salvia-Roigés, María; León-Lozano, Marisol; Rodríguez-Miguélez, José; Figueras-Aloy, Josep // European Journal of Pediatrics;May2013, Vol. 172 Issue 5, p693 

    Coagulase-negative staphylococci are the most common cause of late-onset sepsis in premature neonates. The optimal approach in persistent coagulase-negative staphylococcal bacteremia, despite adequate treatment with glycopeptides, is not well established. A retrospective study was conducted on...

  • Tetracaine.  // Reactions Weekly;7/8/2006, Issue 1109, p18 

    The article discusses a case report on contact dermatitis in a neonate following topical administration. A preterm male neonate developed contact dermatitis after the application of tetracaine gel to his right arm and right leg. The clinical features of contact dermatitis are mentioned. He was...

  • Early-onset neonatal sepsis due to Cellulosimicrobium cellulans. Casanova-Román, M.; Sanchez-Porto, A.; Gomar, J. L.; Casanova-Bellido, M. // Infection;Aug2010, Vol. 38 Issue 4, p321 

    Cellulosimicrobium cellulans represents a rare human pathogen. Infections have been reported in immunocompromised hosts or in patients with an underlying disease. The authors describe a rare case of early-onset neonatal sepsis due to Cellulosimicrobium cellulans in an infant without any...

  • Vancomycin. de Hoog, Matthijs; Moutonz, Johan W.; van den Anker, John N. // Clinical Pharmacokinetics;2004, Vol. 43 Issue 7, p417 

    This review describes the use of vancomycin in neonates over the last three decades. Given the relation of late-onset neonatal septicaemia to outcome and the increase in coagulase-negative staphylococcal infection as causative organism, vancomycin remains an important antibacterial in the...

  • BACTERIOLOGICAL PROFILE AND ANTIBIOGRAM OF NEONATAL SEPTICEMIA. Bhatt, Sima K.; Patel, Disha A.; Gupta, Praveg; Patel, Kiran; Joshi, Gurudutt // National Journal of Community Medicine;Apr-Jun2012, Vol. 3 Issue 2, p238 

    Background: Early diagnosis and proper management of neonatal septicemia can bring down the morbidity and mortality substantially.4 Hence the aim of this study was to study the bacteriological profile of neonatal septicemia cases and their antibiogram for planning strategy for the management of...


Read the Article


Sign out of this library

Other Topics